Mini Michael

1.5k total citations
32 papers, 612 citations indexed

About

Mini Michael is a scholar working on Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Nephrology. According to data from OpenAlex, Mini Michael has authored 32 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 13 papers in Pediatrics, Perinatology and Child Health and 9 papers in Nephrology. Recurrent topics in Mini Michael's work include Kidney Stones and Urolithiasis Treatments (12 papers), Pediatric Urology and Nephrology Studies (10 papers) and Renal Diseases and Glomerulopathies (6 papers). Mini Michael is often cited by papers focused on Kidney Stones and Urolithiasis Treatments (12 papers), Pediatric Urology and Nephrology Studies (10 papers) and Renal Diseases and Glomerulopathies (6 papers). Mini Michael collaborates with scholars based in United States, Australia and Israel. Mini Michael's co-authors include Jonathan C. Craig, Elisabeth M Hodson, Stuart L. Goldstein, Ingrid Kuehnle, Greta Ridley, Elizabeth Elliott, Virginia A. Moyer, Sarah Martin, Richard J. Smith and Sarah E. Sartain and has published in prestigious journals such as The Lancet, PEDIATRICS and Cochrane Database of Systematic Reviews.

In The Last Decade

Mini Michael

31 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mini Michael United States 12 229 177 159 145 140 32 612
Άννα Ταπάρκου Greece 16 150 0.7× 196 1.1× 170 1.1× 105 0.7× 206 1.5× 46 731
Maria Roszkowska–Blaim Poland 12 276 1.2× 46 0.3× 89 0.6× 116 0.8× 74 0.5× 80 517
Therese Jungraithmayr Austria 16 380 1.7× 440 2.5× 60 0.4× 69 0.5× 98 0.7× 33 869
Gaëlle Pellé France 8 117 0.5× 72 0.4× 77 0.5× 77 0.5× 215 1.5× 11 478
Sylvie Nathanson France 12 174 0.8× 230 1.3× 43 0.3× 104 0.7× 56 0.4× 32 532
Pornsak Dissaneewate Thailand 14 232 1.0× 43 0.2× 61 0.4× 113 0.8× 128 0.9× 33 541
D. E. Müller‐Wiefel Germany 14 256 1.1× 60 0.3× 149 0.9× 107 0.7× 41 0.3× 39 677
M.A. Gentil Spain 23 214 0.9× 88 0.5× 92 0.6× 191 1.3× 442 3.2× 59 1.3k
E. Renoult France 19 195 0.9× 106 0.6× 169 1.1× 79 0.5× 218 1.6× 67 1.1k
J Jeffery Canada 16 239 1.0× 81 0.5× 260 1.6× 131 0.9× 130 0.9× 34 1.2k

Countries citing papers authored by Mini Michael

Since Specialization
Citations

This map shows the geographic impact of Mini Michael's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mini Michael with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mini Michael more than expected).

Fields of papers citing papers by Mini Michael

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mini Michael. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mini Michael. The network helps show where Mini Michael may publish in the future.

Co-authorship network of co-authors of Mini Michael

This figure shows the co-authorship network connecting the top 25 collaborators of Mini Michael. A scholar is included among the top collaborators of Mini Michael based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mini Michael. Mini Michael is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Michael, Mini, Elizabeth Harvey, Dawn S. Milliner, et al.. (2024). Diagnosis and management of primary hyperoxalurias: best practices. Pediatric Nephrology. 39(11). 3143–3155. 10 indexed citations
2.
Frishberg, Yaacov, Wesley Hayes, Hadas Shasha‐Lavsky, et al.. (2024). Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trial. Frontiers in Pediatrics. 12. 1392644–1392644. 1 indexed citations
3.
Lieske, John C., Daniella Magen, Hadas Shasha‐Lavsky, et al.. (2023). Lumasiran for Primary Hyperoxaluria Type 1 and Impaired Kidney Function: 24-Month Analysis of the Phase 3 ILLUMINATE-C Trial. Journal of the American Society of Nephrology. 34(11S). 566–566. 1 indexed citations
4.
Hayes, Wesley, David J. Sas, Daniella Magen, et al.. (2022). Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trial. Pediatric Nephrology. 38(4). 1075–1086. 30 indexed citations
5.
Michael, Mini, et al.. (2020). A Zebra at the Rodeo: Dyspnea, Hematuria, and a Family History of Arthritis. Arthritis Care & Research. 74(2). 165–170. 5 indexed citations
6.
Hicks, John, Mini Michael, David T. Selewski, et al.. (2020). Renal Survival in Children with Glomerulonephritis with Crescents: A Pediatric Nephrology Research Consortium Cohort Study. Journal of Clinical Medicine. 9(8). 2385–2385. 12 indexed citations
7.
Runolfsdottir, Hrafnhildur L., Tzu-Ling Lin, David S. Goldfarb, et al.. (2020). Are conventional stone analysis techniques reliable for the identification of 2,8-dihydroxyadenine kidney stones? A case series. Urolithiasis. 48(4). 337–344. 3 indexed citations
8.
Smoyer, William E., Christoph Licht, Sharon Bartosh, et al.. (2020). Long-Term Outcomes of C3 Glomerulopathy and Immune-Complex Membranoproliferative Glomerulonephritis in Children. Kidney International Reports. 5(12). 2313–2324. 13 indexed citations
9.
Michael, Mini, Georges Deschênes, Pierre Cochat, et al.. (2020). ILLUMINATE-B, a Phase 3 Open-Label Study to Evaluate Lumasiran, an RNAi Therapeutic, in Young Children with Primary Hyperoxaluria Type 1 (PH1). Journal of the American Society of Nephrology. 31(10S). 515–515. 5 indexed citations
10.
Michael, Mini, et al.. (2017). Medical Nutrition Therapy for Pediatric Kidney Stone Prevention, Part Two. Journal of Renal Nutrition. 27(2). e11–e14. 5 indexed citations
11.
Wu, Xiaoyan, Molly Wong Vega, Sarah J. Swartz, & Mini Michael. (2017). Milky appearance of peritoneal fluid in a neonate on peritoneal dialysis due to end-stage renal disease: Answers. Pediatric Nephrology. 33(1). 73–76. 2 indexed citations
12.
Bechara, Carlos F., et al.. (2016). A case of gross hematuria with flank pain in a 16-year-old boy: Answers. Pediatric Nephrology. 32(8). 1345–1347. 2 indexed citations
13.
Michael, Mini, et al.. (2016). Medical Nutrition Therapy for Pediatric Kidney Stone Prevention, Part One. Journal of Renal Nutrition. 27(1). e5–e8. 5 indexed citations
14.
Bechara, Carlos F., et al.. (2016). A case of gross hematuria with flank pain in a 16-year-old boy: Questions. Pediatric Nephrology. 32(8). 1343–1344. 3 indexed citations
15.
Michael, Mini, Charles G. Minard, Arundhati S. Kale, & Eileen D. Brewer. (2015). Outcomes of two‐drug maintenance immunosuppression for pediatric renal transplantation: 10‐yr follow‐up in a single center. Pediatric Transplantation. 20(1). 49–58. 4 indexed citations
16.
Miller, Christopher W. T., et al.. (2010). Molecular defects in the mannose binding lectin pathway in dermatological disease: Case report and literature review. Clinical and Molecular Allergy. 8(1). 6–6. 15 indexed citations
17.
Michael, Mini, Elizabeth Elliott, Greta Ridley, Elisabeth M Hodson, & Jonathan C. Craig. (2009). Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura. Cochrane Database of Systematic Reviews. CD003595–CD003595. 71 indexed citations
18.
Michael, Mini, Elizabeth Elliott, Jonathan C. Craig, Greta Ridley, & Elisabeth M Hodson. (2008). Interventions for Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura: A Systematic Review of Randomized Controlled Trials. American Journal of Kidney Diseases. 53(2). 259–272. 79 indexed citations
19.
Michael, Mini, Eileen D. Brewer, & Stuart L. Goldstein. (2004). Blood volume monitoring to achieve target weight in pediatric hemodialysis patients. Pediatric Nephrology. 19(4). 432–437. 23 indexed citations
20.
Michael, Mini, Ingrid Kuehnle, & Stuart L. Goldstein. (2003). Fluid overload and acute renal failure in pediatric stem cell transplant patients. Pediatric Nephrology. 19(1). 91–95. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Άννα Ταπάρκου Breakdown of academic impact, for papers by Maria Roszkowska–Blaim Breakdown of academic impact, for papers by Therese Jungraithmayr Breakdown of academic impact, for papers by Gaëlle Pellé Breakdown of academic impact, for papers by Sylvie Nathanson Breakdown of academic impact, for papers by Pornsak Dissaneewate Breakdown of academic impact, for papers by D. E. Müller‐Wiefel Breakdown of academic impact, for papers by M.A. Gentil Breakdown of academic impact, for papers by E. Renoult Breakdown of academic impact, for papers by J Jeffery
Rankless by CCL
2026